Just 20 years ago SocraTec R&D was formally founded as company by a group of enthusiastic scientists who wanted to establish a privately owned platform for their scientific activities. It took us 9 months until the first subject was dosed in May 1999 – 9 months of very intensive work and a highly active set-up phase. This first clinical trial of SocraTec R&D was published many years later – a PK PD trial in postmenopausal women (https://www.ncbi.nlm.nih.gov/pubmed/22257576)